– Investigational Long-Acting, Twice-Yearly Treatment Regimen of Lenacapavir and Broadly Neutralizing Antibodies (bNAbs) Meets Primary Endpoint in Phase 2 Study and Gains Breakthrough Therapy ...
UCSF researchers recently gave an overview of their latest work launching a new Institute for HIV Cure Research, funded by a $20 million grant from amfAR, the Foundation for AIDS Research. Cure ...
SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they ...
US-supported international HIV research, particularly that conducted in African countries, has direct benefits to Americans. Cuts to that research may undermine those benefits.
"Cure" was the fresh buzzword among researchers at the XIX International AIDS Conference. It was the focus of a two-day pre-conference workshop and a new initiative by the International AIDS Society ...
S1: Hey there , San Diego. It's Andrew Bracken in for Jade Hindman. Today , what do cuts in federal funding mean for the future of HIV and Aids programs around the world ? Plus , how progress being ...
Termination of HIV vaccine studies affects key research institutions, aligning with previous cuts to HIV-related programs under the Trump administration. The administration plans to focus on existing ...
You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...
The National Institutes of Health will distribute approximately $30 million annually over the next five years to six research coalitions working to find a cure for HIV. While medical advances in ...
Hosted on MSN
How a potential HIV cure may affect transmission
A mathematical modeling study coordinated by UMC Utrecht has shown that sustained HIV remission (without rebound) or HIV eradication cure scenarios could consistently reduce new HIV infections among ...
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their blood. Yet that reality is limited to ...
The 22nd Conference on Retroviruses and Opportunistic Infections that took place last month in Seattle is one of the largest scientific conferences on HIV and hepatitis C virus (HCV) research in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results